Even when patients, doctors and health systems emphasize time to treat, insurance processes can delay treatment.
In the first episode of the American Medical Association’s Doc Talk podcast, Timothy Gilligan, MD, and Mikkael Sekeres, MD, discuss how they provide comfort and guidance to patients facing death.
How an oncologist’s experience caring for his mother during lung cancer diagnosis and treatment prompted three resolutions for future interactions with patients.
Mikkael Sekeres, MD, MS, played an unfamiliar role in a familiar setting when his mother was diagnosed with lung cancer.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Mikkael Sekeres, MD, MS, only understood his father’s passion for art on canvas after his father’s deteriorating health revealed the passion’s purpose.
The FDA has approved the immunocellular therapy for use in children and young adults with relapsed/refractory B-cell precursor ALL.
The Director of Cleveland Clinic’s Leukemia Program argues that we must define trial outcomes that matter to patients.
Early trial data show that precision therapy enasidenib can induce durable complete remission in patients with relapsed/refractory acute myeloid leukemia.
Cleveland Clinic has joined a multicenter clinical trial aimed at developing a blood test to detect cancer early. The Circulating Cell-free Genome Atlas (CCGA) study is recruiting 10,000 patients throughout the U.S. to build a database for cancer biology.
When patients communicate their desires, Mikkael Sekeres, MD, MS, says physicians must listen, even if that means sacrificing a firm diagnosis. A 97-year-old patient reminds him that answers aren’t always the answer.